Evaluation and Intervention for the Effects of Osteogenesis Imperfecta
Evaluation and Intervention for Ambulation, Growth, and Basilar Invagination in Osteogenesis Imperfecta
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
A observational or N/A phase clinical study on Osteogenesis Imperfecta, this trial is completed. The trial is conducted by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and has accumulated 75 data snapshots since 1997. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Study Description(click to expand)We propose a longitudinal study of the natural history of types III and IV osteogenesis imperfecta for children age birth to 30 years. A consistent objective throughout this study is to obtain a comprehensive assessment of the natural history and progression of the multiple secondary features of osteogenesis imperfecta. In addition to radiographic, bone density, physical rehabilitation and dental manifestations, we will assess the cardiovascular, pulmonary, neurological, and audiology systems. The major objectives of this protocol focus on rehabilitation and physical therapy studies, pulmonary and cardiovascular function, neurological features, audiological studies and genetic and molecular biology aspects of OI. A major objective in this study is to expand the intensive rehabilitation and physical therapy studies of children with types III and IV OI. This objective continues the work that has been done in the Rehabilitation Department of the Clinical Center for the past 20 years on these patients. However, the focus of this objective is changing to include studies of scoliosis and its effect on function, studies of chest proportions and rib deformities, and studies of nonkinetic variables related to motor performance, such as temperament, competence, coping, and resilience in children with OI. The second major objective is the longitudinal...
We propose a longitudinal study of the natural history of types III and IV osteogenesis imperfecta for children age birth to 30 years. A consistent objective throughout this study is to obtain a comprehensive assessment of the natural history and progression of the multiple secondary features of osteogenesis imperfecta. In addition to radiographic, bone density, physical rehabilitation and dental manifestations, we will assess the cardiovascular, pulmonary, neurological, and audiology systems.
The major objectives of this protocol focus on rehabilitation and physical therapy studies, pulmonary and cardiovascular function, neurological features, audiological studies and genetic and molecular biology aspects of OI. A major objective in this study is to expand the intensive rehabilitation and physical therapy studies of children with types III and IV OI. This objective continues the work that has been done in the Rehabilitation Department of the Clinical Center for the past 20 years on these patients. However, the focus of this objective is changing to include studies of scoliosis and its effect on function, studies of chest proportions and rib deformities, and studies of nonkinetic variables related to motor performance, such as temperament, competence, coping, and resilience in children with OI. The second major objective is the longitudinal study of pulmonary function in children with types III and IV OI. It is well known that cardiopulmonary complications are a major cause of disability and death in adults with OI; the developmental patterns of these complications, and whether susceptible individuals can be identified in childhood, is unknown. The third major objective of these studies of secondary features is to determine the incidence of basilar invagination and develop a monitoring and management plan for this neurological feature. Next, the prevalence, severity, age of onset and genotypic/phenotypic correlation of hearing loss among children with types II and IV OI remains poorly understood; therefore, the study of audiological features is our fourth major objective. The final major objective in this study is the continued study of the genetic and molecular biology aspect of OI. Patients will have skin biopsies for collagen studies at the biochemical and molecular level. Parents will have blood drawn for determination of mosaic status for the mutation that causes their child s OI. These studies will provide further information on genotype/phenotype correlation and other variables in OI genetics. As appropriate, bone chips from emergency or elective surgical procedures on the participants will be used to study osteoblast function in OI.
Status Flow
Change History
75 versions recorded-
Apr 28, 2026 — Present [daily]
Completed
-
Feb 2026 — Apr 2026 [monthly]
Completed
-
Jan 2026 — Feb 2026 [monthly]
Completed
-
Dec 2025 — Jan 2026 [monthly]
Completed
-
Nov 2025 — Dec 2025 [monthly]
Completed
▶ Show 70 earlier versions
-
Oct 2025 — Nov 2025 [monthly]
Completed
-
Sep 2025 — Oct 2025 [monthly]
Completed
-
Jul 2025 — Sep 2025 [monthly]
Completed
-
Jun 2025 — Jul 2025 [monthly]
Completed
-
Apr 2025 — Jun 2025 [monthly]
Completed
-
Mar 2025 — Apr 2025 [monthly]
Completed
-
Feb 2025 — Mar 2025 [monthly]
Completed
-
Jan 2025 — Feb 2025 [monthly]
Completed
-
Dec 2024 — Jan 2025 [monthly]
Completed
-
Nov 2024 — Dec 2024 [monthly]
Completed
-
Oct 2024 — Nov 2024 [monthly]
Completed
-
Sep 2024 — Oct 2024 [monthly]
Completed
-
Aug 2024 — Sep 2024 [monthly]
Completed
-
Jul 2024 — Aug 2024 [monthly]
Completed
-
May 2024 — Jul 2024 [monthly]
Completed
-
Mar 2024 — May 2024 [monthly]
Completed
-
Feb 2024 — Mar 2024 [monthly]
Completed
-
Jan 2024 — Feb 2024 [monthly]
Completed
-
Dec 2023 — Jan 2024 [monthly]
Completed
-
Nov 2023 — Dec 2023 [monthly]
Completed
-
Oct 2023 — Nov 2023 [monthly]
Completed
-
Sep 2023 — Oct 2023 [monthly]
Completed
-
Aug 2023 — Sep 2023 [monthly]
Completed
-
Jul 2023 — Aug 2023 [monthly]
Completed
-
Jun 2023 — Jul 2023 [monthly]
Completed
-
May 2023 — Jun 2023 [monthly]
Completed
-
Apr 2023 — May 2023 [monthly]
Completed
-
Mar 2023 — Apr 2023 [monthly]
Completed
-
Feb 2023 — Mar 2023 [monthly]
Completed
-
Dec 2022 — Feb 2023 [monthly]
Completed
-
Nov 2022 — Dec 2022 [monthly]
Completed
-
Sep 2022 — Nov 2022 [monthly]
Completed
-
Jul 2022 — Sep 2022 [monthly]
Completed
-
Jun 2022 — Jul 2022 [monthly]
Completed
-
May 2022 — Jun 2022 [monthly]
Completed
-
Apr 2022 — May 2022 [monthly]
Completed
-
Mar 2022 — Apr 2022 [monthly]
Completed
-
Feb 2022 — Mar 2022 [monthly]
Completed
-
Jan 2022 — Feb 2022 [monthly]
Completed
-
Dec 2021 — Jan 2022 [monthly]
Completed
-
Nov 2021 — Dec 2021 [monthly]
Completed
-
Oct 2021 — Nov 2021 [monthly]
Completed
-
Sep 2021 — Oct 2021 [monthly]
Completed
-
Jun 2021 — Sep 2021 [monthly]
Completed
-
May 2021 — Jun 2021 [monthly]
Completed
-
Apr 2021 — May 2021 [monthly]
Completed
-
Mar 2021 — Apr 2021 [monthly]
Completed
-
Feb 2021 — Mar 2021 [monthly]
Completed
-
Jan 2021 — Feb 2021 [monthly]
Completed
-
Oct 2020 — Jan 2021 [monthly]
Completed
-
Jun 2020 — Oct 2020 [monthly]
Completed
-
May 2020 — Jun 2020 [monthly]
Completed
-
Mar 2020 — May 2020 [monthly]
Completed
-
Aug 2019 — Mar 2020 [monthly]
Completed
-
Jun 2019 — Aug 2019 [monthly]
Completed
-
May 2019 — Jun 2019 [monthly]
Completed
-
Apr 2019 — May 2019 [monthly]
Completed
-
Mar 2019 — Apr 2019 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Jan 2019 — Mar 2019 [monthly]
Active Not Recruiting
-
Dec 2018 — Jan 2019 [monthly]
Active Not Recruiting
-
Oct 2018 — Dec 2018 [monthly]
Active Not Recruiting
-
Sep 2018 — Oct 2018 [monthly]
Active Not Recruiting
-
Aug 2018 — Sep 2018 [monthly]
Active Not Recruiting
-
Jul 2018 — Aug 2018 [monthly]
Active Not Recruiting
-
Jun 2018 — Jul 2018 [monthly]
Active Not Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Active Not Recruiting
Phase: NA → None
-
Jan 2018 — Apr 2018 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Jun 2017 — Jan 2018 [monthly]
Recruiting NA
-
May 2017 — Jun 2017 [monthly]
Recruiting NA
-
Jan 2017 — May 2017 [monthly]
Recruiting NA
First recorded
Jan 1997
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
We propose a longitudinal study of the natural history of types III and IV osteogenesis imperfecta for children age birth to 25 years. A consistent objective throughout this study is to obtain a comprehensive assessment of the natural history and progression of the multiple secondary features of osteogenesis imperfecta. In addition to radiographic, bone density, physical rehabilitation and dental manifestations, we will assess the cardiovascular, pulmonary, neurological, and audiology systems. The major objectives of this protocol focus on rehabilitation and physical therapy studies, pulmonary and cardiovascular function, neurological features, audiological studies and genetic and molecular biology aspects of OI. A major objective in this study is to expand the intensive rehabilitation and physical therapy studies of children with types III and IV OI. This objective continues the work that has been done in the Rehabilitation Department of the Clinical Center for the past 20 years on these patients. However, the focus of this objective is changing to include studies of scoliosis and its effect on function, studies of chest proportions and rib deformities, and studies of nonkinetic variables related to motor performance, such as temperament, competence, coping, and resilience in children with OI. The second major objective is the longitudinal study of pulmonary function in children with types III and IV OI. It is well known that cardiopulmonary complications are a major cause of disability and death in adults with OI; the developmental patterns of these complications, and whether susceptible individuals can be identified in childhood, is unknown. The third major objective of these studies of secondary features is to determine the incidence of basilar invagination and develop a monitoring and management plan for this neurological feature. Next, the prevalence, severity, age of onset and genotypic/phenotypic correlation of hearing loss among children with types II and IV OI remains poorly understood; therefore, the study of audiological features is our fourth major objective. The final major objective in this study is the continued study of the genetic and molecular biology aspect of OI. Patients will have skin biopsies for collagen studies at the biochemical and molecular level. Parents will have blood drawn for determination of mosaic status for the mutation that causes their child s OI. These studies will provide further information on genotype/phenotype correlation and other variables in OI genetics. As appropriate, bone chips from emergency or elective surgical procedures on the participants will be used to study osteoblast function in OI.
Contact Information
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
For direct contact, visit the study record on ClinicalTrials.gov .